Rescinnamine - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for rescinnamine and what is the scope of patent protection?
Rescinnamine
is the generic ingredient in two branded drugs marketed by Panray and Pfizer, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for rescinnamine.
Summary for rescinnamine
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 1,673 |
DailyMed Link: | rescinnamine at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for rescinnamine
US Patents and Regulatory Information for rescinnamine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Panray | CINNASIL | rescinnamine | CAPSULE;ORAL | 084736-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | MODERIL | rescinnamine | TABLET;ORAL | 010686-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | MODERIL | rescinnamine | TABLET;ORAL | 010686-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |